Target Market Large addressable market for memory loss due to traumatic brain injury, with expansion potential into mild cognitive impairment and Alzheimer's segments, presenting multiple entry points for neurostimulation therapy solutions.

Strategic Validation Technology backed by Department of Defense funding and multiple clinical publications, plus a functional demonstration in a large animal model, supporting credibility for pilot programs and early-adopter discussions with medical centers.

Clinical Partnerships Recent collaboration with NIATx and minority health organizations signals openness to community-based deployment and diverse patient access programs, offering co-development and site-access opportunities for trials and early-market adoption.

Regulatory Readiness ISO 13485 and ISO 9001 aligned quality systems with ISO 14971 risk management indicate a roadmap for device manufacturing compliance, streamlining conversations with hospitals and procurement teams on compliant pilot deployments.

Growth Profile Modest headcount with growing funding and revenue, suggesting current focus on strategic partnerships, channel sales, and contract manufacturing arrangements to scale commercialization without heavy upfront operational spend.